JP2012508185A5 - - Google Patents

Download PDF

Info

Publication number
JP2012508185A5
JP2012508185A5 JP2011534934A JP2011534934A JP2012508185A5 JP 2012508185 A5 JP2012508185 A5 JP 2012508185A5 JP 2011534934 A JP2011534934 A JP 2011534934A JP 2011534934 A JP2011534934 A JP 2011534934A JP 2012508185 A5 JP2012508185 A5 JP 2012508185A5
Authority
JP
Japan
Prior art keywords
pge
activity
compound
hematopoietic stem
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011534934A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012508185A (ja
JP5846915B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/063654 external-priority patent/WO2010054271A1/en
Publication of JP2012508185A publication Critical patent/JP2012508185A/ja
Publication of JP2012508185A5 publication Critical patent/JP2012508185A5/ja
Application granted granted Critical
Publication of JP5846915B2 publication Critical patent/JP5846915B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011534934A 2008-11-06 2009-11-06 造血幹細胞の生着手順を強化するための材料および方法 Expired - Fee Related JP5846915B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11201808P 2008-11-06 2008-11-06
US61/112,018 2008-11-06
PCT/US2009/063654 WO2010054271A1 (en) 2008-11-06 2009-11-06 Materials and methds to enhance hematopoietic stem cells engraftment procedures

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015134076A Division JP6632822B2 (ja) 2008-11-06 2015-07-03 造血幹細胞の生着手順を強化するための材料および方法

Publications (3)

Publication Number Publication Date
JP2012508185A JP2012508185A (ja) 2012-04-05
JP2012508185A5 true JP2012508185A5 (https=) 2012-12-20
JP5846915B2 JP5846915B2 (ja) 2016-01-20

Family

ID=42153284

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2011534934A Expired - Fee Related JP5846915B2 (ja) 2008-11-06 2009-11-06 造血幹細胞の生着手順を強化するための材料および方法
JP2015134076A Expired - Fee Related JP6632822B2 (ja) 2008-11-06 2015-07-03 造血幹細胞の生着手順を強化するための材料および方法
JP2017195168A Withdrawn JP2018048156A (ja) 2008-11-06 2017-10-05 造血幹細胞の生着手順を強化するための材料および方法
JP2019217044A Withdrawn JP2020063263A (ja) 2008-11-06 2019-11-29 造血幹細胞の生着手順を強化するための材料および方法
JP2023001015A Pending JP2023052244A (ja) 2008-11-06 2023-01-06 造血幹細胞の生着手順を強化するための材料および方法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2015134076A Expired - Fee Related JP6632822B2 (ja) 2008-11-06 2015-07-03 造血幹細胞の生着手順を強化するための材料および方法
JP2017195168A Withdrawn JP2018048156A (ja) 2008-11-06 2017-10-05 造血幹細胞の生着手順を強化するための材料および方法
JP2019217044A Withdrawn JP2020063263A (ja) 2008-11-06 2019-11-29 造血幹細胞の生着手順を強化するための材料および方法
JP2023001015A Pending JP2023052244A (ja) 2008-11-06 2023-01-06 造血幹細胞の生着手順を強化するための材料および方法

Country Status (10)

Country Link
US (5) US9107909B2 (https=)
EP (3) EP2362733B1 (https=)
JP (5) JP5846915B2 (https=)
CN (4) CN108379292A (https=)
AU (4) AU2009313290B2 (https=)
CA (3) CA3203374A1 (https=)
ES (1) ES2845641T3 (https=)
PT (1) PT3031907T (https=)
WO (1) WO2010054271A1 (https=)
ZA (1) ZA201804932B (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL296832A (en) 2005-10-18 2022-11-01 Nat Jewish Health Process of preparing red blood cells using conditionally immortalized long-term hematopoietic stem cells and erythropoietin
SG10201803982TA (en) 2008-05-16 2018-07-30 Taiga Biotechnologies Inc Antibodies and processes for preparing the same
DK3339321T3 (da) 2008-08-28 2021-06-21 Taiga Biotechnologies Inc Modulatorer af myc, fremgangsmåder til anvendelse af samme og fremgangsmåder til at identificere stoffer der modulerer myc
CN108379292A (zh) 2008-11-06 2018-08-10 印第安纳大学研究与技术公司 增强造血干细胞植入过程的材料和方法
US10813917B2 (en) 2009-12-11 2020-10-27 Medregen, Llc Treatment methods utilizing stem cell mobilizers and immunosuppressive agents
ES2654994T3 (es) * 2010-08-12 2018-02-15 Fate Therapeutics, Inc. Terapia mejorada con células madre y precursoras hematopoyéticas
US10213464B2 (en) * 2011-01-13 2019-02-26 Scipharm Sarl Method for enhancing engraftment of haematopoetic stem cells
ES2769270T3 (es) * 2011-09-30 2020-06-25 Bluebird Bio Inc Compuestos para transducción viral mejorada
EP2785350B1 (en) 2011-12-02 2018-05-02 Fate Therapeutics, Inc. Improved methods of treating ischemia
JP6220791B2 (ja) 2011-12-02 2017-10-25 フェイト セラピューティクス，インコーポレイテッド 増強された幹細胞組成物
US9233127B2 (en) 2012-02-29 2016-01-12 University Of Virginia Patent Foundation Compositions and methods for CXCR4 signaling and umbilical cord blood stem cell engraftment
WO2014015318A1 (en) * 2012-07-19 2014-01-23 Bluebird Bio, Inc. Soluble compounds for improved gene therapy methods
US9789135B2 (en) * 2012-07-20 2017-10-17 Taiga Biotechnologies, Inc. Enhanced reconstitution and autoreconstitution of the hematopoietic compartment
US20150216903A1 (en) * 2012-08-10 2015-08-06 Bluebird Bio, Inc. Compounds for improved viral transduction
KR102503695B1 (ko) 2013-02-28 2023-02-23 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 줄기세포를 동원하기 위한 방법 및 조성물
US10272115B2 (en) 2013-03-11 2019-04-30 Taiga Biotechnologies, Inc. Production and use of red blood cells
WO2014150602A1 (en) 2013-03-15 2014-09-25 Fate Therapeutics, Inc. Cell potency assay for therapeutic potential
US9943545B2 (en) * 2013-03-15 2018-04-17 Fate Therapeutics, Inc. Stem cell culture media and methods of enhancing cell survival
CN105658217B (zh) 2013-04-29 2021-03-19 约翰霍普金斯大学 经由自体干细胞动员的创伤愈合
KR101489861B1 (ko) * 2013-05-07 2015-02-05 경북대학교 산학협력단 Amd3100을 포함하는 골질환 예방 또는 치료용 조성물
US20180112180A1 (en) 2015-01-26 2018-04-26 Fate Therapeutics, Inc. Cells with increased immuno-regulatory properties and methods for their use and manufacture
CN104774806B (zh) * 2015-04-09 2019-02-15 广州赛莱拉干细胞科技股份有限公司 一种胎盘造血干细胞的制备方法
US20180214487A1 (en) 2015-07-21 2018-08-02 The Children's Medical Center Corporation Pd-l1 expressing hematopoietic stem cells and uses
IL261002B2 (en) 2016-02-12 2024-07-01 Bluebird Bio Inc Vcn enhancer compositions and methods of using the same
WO2017139561A1 (en) 2016-02-12 2017-08-17 Bluebird Bio, Inc. Vcn enhancer compositions and methods of using the same
EP3419617A4 (en) * 2016-02-26 2019-10-23 President and Fellows of Harvard College HIGH GRADE TRANSPLANTABLE HEMATOPOETIC STEM CELLS
WO2018017341A1 (en) * 2016-07-22 2018-01-25 Senlin Li Methods and compositions for rejuvenation
EP3548425B1 (en) 2016-12-02 2023-03-29 Taiga Biotechnologies, Inc. Nanoparticle formulations
EP3574088A4 (en) * 2017-01-27 2020-09-23 Children's Hospital Medical Center PROCESSES FOR IMPROVING HEMATOPOIETIC STEM CELL TRANSPLANT ACTIVITY
US10149898B2 (en) 2017-08-03 2018-12-11 Taiga Biotechnologies, Inc. Methods and compositions for the treatment of melanoma
US11213546B2 (en) 2017-09-07 2022-01-04 Emory University Methods to mobilize tissue resident cells for adoptive t cell therapy
US11879137B2 (en) 2017-09-22 2024-01-23 The Children's Medical Center Corporation Treatment of type 1 diabetes and autoimmune diseases or disorders
FR3074189A1 (fr) * 2017-11-30 2019-05-31 Assistance Publique - Hopitaux De Paris Methode de generation de greffons de cellules souches hematopoietiques
CN108404112B (zh) * 2018-04-01 2020-05-12 北京诺赛启研再生医学研究院有限公司 提高造血干细胞归巢及植入率的方法及其试剂
EP3647413A1 (en) * 2018-10-31 2020-05-06 Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas O.A., M.P. (CIEMAT) Improvements for performing and facilitating the recovery after hematopoietic stem cell transplantation
CN113874033A (zh) 2019-04-08 2021-12-31 泰加生物工艺学公司 用于冷冻保存免疫细胞的组合物和方法
EP3969041A4 (en) 2019-05-14 2023-05-10 Taiga Biotechnologies, Inc. COMPOSITIONS AND METHODS FOR TREATMENT OF T-CELL DEPLETION
KR20220160018A (ko) 2020-03-31 2022-12-05 덴카 주식회사 알루미나 분말, 수지 조성물, 및 방열 부품
CN116509834B (zh) * 2023-01-20 2025-05-13 东北师范大学 化合物在制备造血干/祖细胞增殖和损伤修复药物中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399493A (en) * 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
JPH08205860A (ja) * 1994-01-21 1996-08-13 Usa Government 造血細胞の膨大化および移植方法
US5928638A (en) * 1996-06-17 1999-07-27 Systemix, Inc. Methods for gene transfer
RU2305708C2 (ru) * 2001-10-02 2007-09-10 Энститю Клейтон Де Ля Решерш Рекомбинантный лентивирусный вектор, клетка-хозяин, трансдуцированная лентивирусным вектором, способ ее трансдукции и применение
EP1461087A1 (en) * 2001-12-06 2004-09-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders
WO2003065871A2 (en) * 2002-02-04 2003-08-14 Millennium Pharmaceuticals Inc. Methods and compositions for treating hematological disorders
EP1613742A2 (en) 2003-04-08 2006-01-11 YEDA RESEARCH AND DEVELOPMENT Co. LTD. Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same
IL158868A0 (en) 2003-11-13 2004-05-12 Yeda Res & Dev Methods of generating and using stem cells enriched with immature primitive progenitor
JP5315611B2 (ja) 2004-06-23 2013-10-16 小野薬品工業株式会社 Ｓ１ｐ受容体結合能を有する化合物およびその用途
US20080021078A1 (en) 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Methods and medicaments for administration of ibuprofen
US20070087988A1 (en) 2005-09-30 2007-04-19 New York University Hematopoietic progenitor kinase 1 for modulation of an immune response
JP2007099724A (ja) 2005-10-06 2007-04-19 Shizuoka Prefecture スルファチドを標的とした抗ウイルス剤
WO2007047372A2 (en) * 2005-10-14 2007-04-26 The Board Of Trustees Of The University Of Illinois Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists
RU2425876C2 (ru) 2006-03-24 2011-08-10 Чилдрен'З Медикал Сентер Корпорейшн Способ модулирования роста гематопоэтических стволовых клеток
WO2007148332A1 (en) 2006-06-22 2007-12-27 Yeda Resaerch And Development Co. Ltd Catecholamine receptor modulation
EP3824885A1 (en) 2006-10-20 2021-05-26 Children's Medical Center Corporation Method to enhance tissue regeneration
EP2094839B1 (en) * 2006-12-08 2020-02-05 University of Rochester Expansion of hematopoietic stem cells
US8598328B2 (en) 2006-12-13 2013-12-03 National University Corporation Nagoya University Tol1 factor transposase and DNA introduction system using the same
CN108379292A (zh) 2008-11-06 2018-08-10 印第安纳大学研究与技术公司 增强造血干细胞植入过程的材料和方法
WO2010108028A2 (en) 2009-03-19 2010-09-23 Fate Therapeutics, Inc. Compositions comprising cyclic amp enhancers and/or ep ligands, and methods of preparing and using the same
ES2769270T3 (es) 2011-09-30 2020-06-25 Bluebird Bio Inc Compuestos para transducción viral mejorada

Similar Documents

Publication Publication Date Title
JP2012508185A5 (https=)
JP6632822B2 (ja) 造血幹細胞の生着手順を強化するための材料および方法
US20160354385A1 (en) Method to enhance tissue regeneration
RU2013138569A (ru) Антагонисты рецептора минералокортикоидов
RU2009131454A (ru) Способы предупреждения или уменьшения числа обострений подагры с применением ингибиторов ксантиноксидоредуктазы и противовоспалительных средств
RU2011149256A (ru) Пестицидные композиции
JP2014012726A (ja) キサンチン酸化還元酵素阻害剤を使用する腎機能保持方法
JP2007224037A (ja) Ｃｄ１１／ｃｄ１８接着レセプター媒介疾患の治療用アンタゴニスト
RU2008134423A (ru) Новые производные пиридина
EP1676574A2 (en) Methods for promoting survival of transplanted tissues and cells
US20190365733A1 (en) Methods of improving cell-based therapy
JP2014502979A5 (https=)
US12351609B2 (en) Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload
BR112018006866B1 (pt) Compostos agonistas de ppar, composições farmacêuticas e métodos de uso dos mesmos
CA3014728A1 (en) Methods of treating diseases characterised by vasoconstriction
Kandhi et al. EETs promote hypoxic pulmonary vasoconstriction via constrictor prostanoids
WO2004047772A2 (en) Catalytic antioxidants and methods of use
Hamada et al. Novel BACE1 inhibitors possessing a 5-nitroisophthalic scaffold at the P2 position
Duncan Mechanical support for cardiac and respiratory failure in pediatric patients
Zhou et al. In silico observation of the conformational opening of the glutathione-binding site of microsomal prostaglandin E2 synthase-1
US20200129523A1 (en) Ship inhibition to induce expression of granulocyte colony stimulating factor in a subject
Chan et al. Protective effects of histamine on Gq-mediated relaxation in regenerated endothelium
JP2008531545A5 (https=)
JP7658909B2 (ja) 筋ジストロフィー治療薬
Hasan et al. Early postnatal ibuprofen and indomethacin effects in suckling and weanling rat kidneys